Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division Sort descending
  • Business
  • Functional Area
  • Date Posted
Job Title Site Location Division Sort descending Business Functional Area Date Posted
Product Specialist Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 23, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
Senior MR Guangzhou (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
MR Fuyang (Anhui Province) China International Innovative Medicines Sales Aug 05, 2024
Senior/Advanced Medical/Sales Representative Beijing (Beijing) China International Innovative Medicines Sales Aug 06, 2024
Product Specialist Jingzhou (Hubei Province) China International Innovative Medicines Sales Aug 06, 2024
(高级)医药代表 /(资深)产品专员 Xianyang (Shanxi Province) China International Innovative Medicines Sales Aug 30, 2024
MR Beijing (Beijing) China International Innovative Medicines Sales Sep 01, 2024
Medical Affairs Lead (m/w/d), Solid Tumors Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development Sep 06, 2024
DM Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 18, 2024
Associate Sales Manager Hong Kong Hong Kong Special Administrative Region, China International Innovative Medicines Sales Jul 18, 2024
MR Shenzhen (Guangdong Province) China International Innovative Medicines Sales Jul 22, 2024
Product Specialist Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 23, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
Senior Brand Manager Shanghai (Shanghai) China International Innovative Medicines Marketing Apr 29, 2024
(高级)医药代表 /(资深)产品专员 Chengdu (Sichuan Province) China International Innovative Medicines Sales Apr 29, 2024
MR Beijing (Beijing) China International Innovative Medicines Sales Apr 29, 2024
Area Marketing Manager Chengdu (Sichuan Province) China International Innovative Medicines Marketing Apr 30, 2024
(高级)区域市场经理 Zhengzhou (Henan Province) China International Innovative Medicines Marketing Apr 30, 2024
Product manager (Hematology) Moscow (City) Russian Fed. International Innovative Medicines Marketing May 02, 2024
County Executive Ningde (Fujian Province) China International Innovative Medicines Sales May 06, 2024
Area Marketing Manager Wuhan (Hubei Province) China International Innovative Medicines Marketing May 06, 2024
Product manager (Immunology) Moscow (City) Russian Fed. International Innovative Medicines Marketing Jul 04, 2024
Chef de Projet Omnicanal – Apprenti H/F Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Jul 04, 2024
县域主任/县域主管 Dazhou (Sichuan Province) China International Innovative Medicines Sales Jul 04, 2024
Senior District Manager Zhanjiang (Guangdong Province) China International Innovative Medicines Sales Jul 05, 2024
Public Affairs Manager (m/f/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Communications & Public Affairs Jul 09, 2024
Senior Public Affairs Manager (m/f/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Market Access Sep 03, 2024
RLT Formulation Project Leader Ivrea Italy International Innovative Medicines Research & Development Sep 03, 2024
RLT Analytical Product Project Leader (m/f/d) Ivrea Italy International Innovative Medicines Research & Development Jul 11, 2024
RLT Analytical Expert (m/f/d) Ivrea Italy International Innovative Medicines Research & Development Jul 11, 2024
RLT Drug Product Project Lead (m/f/d) Ivrea Italy International Innovative Medicines Research & Development Jul 11, 2024
Disease Area Specialist Israel Israel International Innovative Medicines Sales Jul 15, 2024
Medical Advisor Shanghai (Shanghai) China International Innovative Medicines Research & Development Jul 15, 2024
RLT HCS & Partnerships Head Shanghai (Shanghai) China International Innovative Medicines Marketing Sep 03, 2024
县域主任/县域主管 Yibin (Sichuan Province) China International Innovative Medicines Sales Sep 10, 2024
Portfolio Account Specialist (Immunology, VIC West) Victoria (VIC) Australia International Innovative Medicines Sales Sep 11, 2024
Public Affairs Manager Ankara Gimat Turkey International Innovative Medicines Communications & Public Affairs Sep 13, 2024
Executive Product Specialist Quanzhou (Fujian Province) China International Innovative Medicines Sales Sep 18, 2024
Head of Data Driven Decision Making New South Wales (NSW) Australia International Innovative Medicines Marketing Sep 19, 2024
KAM/Senior KAM - Oncology - North London Field Force (England / Wales) United Kingdom International Innovative Medicines Sales Sep 20, 2024
Digital Strategy & Insights Manager (f/m/d) Vienna Austria International Innovative Medicines Marketing Sep 20, 2024
Brand manager - Oncology (m/f/d) / Vodja blagovne znamke v onkologiji (m/ž/d) Ljubljana Slovenia International Innovative Medicines Marketing Sep 20, 2024
MR Pingxiang (Jiangxi Province) China International Innovative Medicines Sales Sep 23, 2024
Patient Support Program Lead Seoul South Korea International Innovative Medicines Marketing Sep 24, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Sales Sep 24, 2024
Communication & Patient Advocacy Manager (f/m/d) Vienna Austria International CTS Communications & Public Affairs Sep 24, 2024
Senior MR Guangzhou (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 42
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia